Exploring the Science Behind the Symptoms

Irritable bowel syndrome with diarrhea (IBS-D) is commonly encountered in clinical practice and is associated with discernible symptoms that have substantial impact on the patient.1-4 However, the underlying cause of these symptoms is multifactorial and complex and can vary by patient, limiting management of the disorder to an approach based on symptoms alone.1,2,5-7 Exploring the science behind the symptoms is therefore essential for advancing the management of patients with IBS-D.

Gut microbiome image
Explore the Symptoms of IBS-D
Explore the Science Behind IBS-D Symptoms
IBS-D Up Close is an online resource for healthcare professionals who treat patients with irritable bowel syndrome with diarrhea.

Irritable bowel syndrome with diarrhea (IBS-D) is commonly encountered in clinical practice and is associated with discernible symptoms that have substantial impact on the patient.1-4 However, the underlying cause of these symptoms is multifactorial and complex and can vary by patient, limiting management of the disorder to an approach based on symptoms alone.1,2,5-7 Exploring the science behind the symptoms is therefore essential for advancing the management of patients with IBS-D.

References +

References

  • Lacy BE, Moreau JC. Diarrhea-predominant irritable bowel syndrome: diagnosis, etiology, and new treatment considerations. J Am Assoc Nurse Pract. 2016;28(7):393-404.
  • Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393-1407.
  • Buono JL, Carson RT, Flores NM. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes. 2017;15(1):35.
  • American Gastroenterological Association. IBS in America: Survey Summary Findings. December 2015. http://www.multivu.com/players/English/7634451-aga-ibs-in-america-survey/docs/survey-findings-pdf-635473172.pdf. Accessed March 19, 2018.
  • Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949-958.
  • Oświęcimska J, Szymlak A, Roczniak W, Girczys-Połedniok K, Kwiecień J. New insights into the pathogenesis and treatment of irritable bowel syndrome. Adv Med Sci. 2017;62(1):17-30.
  • Cong X, Perry M, Bernier KM, Young EE, Starkweather A. Effects of self-management interventions in patients with irritable bowel syndrome: systematic review. West J Nurs Res. 2017;Aug 1:193945917727705. doi: 10.1177/0193945917727705.
Salix logo
Use of this site signifies your agreement to the Legal Notice and Privacy Policy.
Salix Pharmaceuticals
400 Somerset Corporate Blvd., Bridgewater, NJ 08807
IBS.0132.USA.18

You are now leaving IBS-D Up Close

You are now leaving IBS-D Up Close and going to a commercial website. We hope you enjoyed your visit and welcome you to come back again to IBS-D Up Close.

ProceedGo Back